Actinium Pharmaceuticals, Inc. (ATNM) has a market capitalization of $34.51M and trades at $1.10. The 52-week range is 0.952-1.945.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1, Earnings Per Share (EPS) of $-1.09, annual revenue of $90K.
The stock has a beta of -0.21, operates in the Healthcare sector.
